Vertex Pharmaceuticals Incorporated (VRTX)
Pre-market:
| Previous close | 349.53 |
| Open | 350.00 |
| Bid | 0.00 x 2200 |
| Ask | 355.09 x 800 |
| Day's range | 344.62 - 350.80 |
| 52-week range | 278.19 - 367.00 |
| Volume | |
| Avg. volume | 1,000,060 |
| Market cap | 90.506B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 27.04 |
| EPS (TTM) | 12.97 |
| Earnings date | 25 Oct 2023 - 30 Oct 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 387.08 |
ZacksVertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know
Vertex Pharmaceuticals (VRTX) closed at $350.67 in the latest trading session, marking a +0.33% move from the prior day.
Motley FoolBuying These 2 Remarkable Growth Stocks in Any Market Could Be a Genius Move
The stock market has had plenty of great trading days in 2023, but the volatility of the 2022 stock market has persisted. The business of a pet store isn't new in and of itself, but Chewy's unique approach to the modern iteration of this model is driving consistent revenue growth and profits. For one, Chewy is a 100% online business.
Motley Fool3 Magnificent Growth Stocks to Buy Right Now
Three Fool.com contributors believe they've identified truly magnificent growth stocks to buy right now. Here's why they chose AstraZeneca (NASDAQ: AZN), Eli Lilly (NYSE: LLY), and Vertex Pharmaceuticals (NASDAQ: VRTX). David Jagielski (AstraZeneca): What makes AstraZeneca a magnificent long-term investment is how broad the business is and the potential it has to generate long-term gains.
